ESOP Transaction and Fiduciary Checklist: A Practical Checklist

Document type: Checklist Practice area: Corporate — Employee Benefits Jurisdiction: United States (federal) Last reviewed: 5 September 2026

Part 1 — Feasibility, before any price discussion

Three cases modeled: management plan, base case, and a downturn case calibrated to the company's own worst two-year period.
Downturn case tested against covenants. If it breaches, the leverage is too high — whatever the base case shows.
Cash flow character assessed: recurring and diversified, or lumpy with working capital swings?
Customer concentration measured accurately (top three as a percentage of revenue).
Debt service plus plan contributions plus capital expenditure all funded in the model. (Contributions are cash, even though deductible under 26 U.S.C. § 404(a)(9).)
Business tested for dependence on the departing owner — which customers would leave, and what transition has occurred?
Management depth and a functioning board confirmed. An ESOP has no controlling shareholder to intervene.
Twenty-year repurchase obligation modeled now, not in year ten.
Who prepared the study? A firm earning a success fee is not independent. Independent look commissioned.

Part 2 — The exit comparison, in writing to the seller

ESOP advantages stated: fair-market liquidity without competitor diligence; § 1042 deferral for a C corporation seller; continuity of place, people, management; tax-exempt operating structure if S status follows; genuine employee benefit.
Disadvantages stated plainly: fair market value, not a strategic premium; real debt; permanent repurchase obligation; ERISA subjection; meaningful transaction costs; deferred liquidity in a subordinated note secured by nothing.
Deal-breakers screened: volatile or thin cash flow, heavy concentration, owner-dependent business, a seller who wants the maximum number.
Timeline stated: 12–18 months typical.
Costs stated, including that the company pays the trustee's fees, its counsel, and its appraiser — the parties negotiating against the seller.
Recurring annual costs stated: appraisal, administration, Form 5500 and testing, § 409(p) testing, trustee fees, fiduciary insurance, repurchase studies.
Seller's own cash flow modeled, including in the downturn case.
Comparison signed off by the seller.

Part 3 — Transaction team with clean roles

Company counsel — represents the company; drafts the plan; advises the board in its appointing-fiduciary capacity.
Seller's counsel — represents the seller, whose interest is legitimate and adverse to the plan.
Trustee's counsel — a separate firm with no prior relationship to the seller.
Appraiser retained by and reporting to the TRUSTEE.
Financial advisor to the trustee, where the transaction warrants a fairness opinion.
Written engagement letters stating whom each firm represents.

Defects to avoid, each of which regulators identify immediately:

The founder's long-time lawyer drafting the plan, advising the board, and negotiating for the seller.
An advisor who originated the deal, wrote the feasibility study, recommended the trustee, and earns a success fee.
An appraiser who has valued the company for the seller's estate planning.

Part 4 — Trustee and appraiser selection

Board appoints the trustee, with the seller recused.
Institutional independent trustee retained for the transaction.
Trustee diligenced: ESOP experience, capacity, insurance, the individuals doing the work, its process. Ask how many transactions it has declined.
Trustee selects its own counsel and its own appraiser through a documented process.
Seller's counsel does not attend trustee deliberations, select the appraiser, or receive valuation drafts.
Rationale understood: § 1106 prohibits the transaction; only the § 1108(e) exemption permits it; its condition is adequate consideration as defined in 29 U.S.C. § 1002(18) — fair market value determined in good faith by the trustee.

Part 5 — Diligence and valuation

Trustee runs full diligence: financial, legal, operational, concentration, key person, environmental, litigation, employment.
Projections tested, not accepted:
- What did last year's projection say, and what happened?
- Projected growth against the ten-year historical rate.
- Support for assumed margin expansion.
- Pipeline under contract versus hoped for.
Valuation methodologies applied: discounted cash flow, guideline public company, guideline transaction.
ESOP-specific overlays addressed: control vs. minority basis; marketability discount adjusted for the repurchase obligation and put right; treatment of transaction debt; dilutive effect of warrants; S corporation tax benefit if conversion follows.
Seller does not pressure the appraiser, request drafts, or communicate price expectations. Every such communication becomes an exhibit.

Part 6 — Negotiation (its absence is the defect looked for first)

Trustee opens below the seller's expectation, informed by diligence findings.
Movement on both sides tied to specific findings.
Whole package negotiated: price, debt mix, seller note rate and amortization, subordination, warrant coverage and strike, post-closing board, seller's continuing role, non-competition, indemnification.
Expectation managed with the seller before the first offer — the number from a success-fee advisor is not the number a fiduciary can pay.
Negotiation history documented by both trustee and company: opening position, exchanges, analysis behind each movement, basis for the final determination.
Fairness opinion obtained, addressed to the trustee.
Trustee's deliberative minutes reflect questions asked, answers received, alternatives considered, and the basis for the conclusion.

Part 7 — Financing and warrants

Senior bank debt sized by the lender's own credit analysis — used as an independent feasibility check.
Seller notes: rate, amortization, subordination terms, standstill, payment blockage, acceleration rights.
Personal guarantees resisted, or bounded in amount and duration.
Warrants valued by the trustee's appraiser and reflected in the price — a warrant that transfers too much future value means the plan overpaid.
Section 409(p) analysis RUN BEFORE warrant terms are finalized. Warrants are synthetic equity; a nonallocation year carries severe consequences.
Internal loan terms and amortization set — they determine the share release rate to participants.
Contribution schedule sized within the § 404(a)(9) deduction limits.
Covenants reviewed by benefits counsel — limits on distributions or contributions constrain the share release rate.
Refinancing and prepayment flexibility negotiated.

Part 8 — Tax elections, in sequence

C corporation status at closing confirmed (an existing S corporation must revoke, with timing and consequences modeled).
Section 1042 requirements met: plan owns ≥ 30% immediately after; seller held ≥ 3 years; qualified replacement property reinvestment within the period beginning 3 months before and ending 12 months after the sale.
Qualified replacement property strategy arranged with the seller's investment advisor BEFORE closing.
Statement of election and consent prepared and filed correctly.
Allocation restrictions on the seller and related persons understood and reflected in the plan.
S election modeled for a later year, with built-in gains analyzed.
Section 409(p) re-tested post-conversion with all synthetic equity included.
Sequence confirmed: C corporation at closing → § 1042 election → S election later → § 409(p) monitoring thereafter.

Part 9 — Closing and the thirty days after

Plan and trust documents executed; trustee appointment documented.
Stock purchase agreement, internal and external loan documents, pledge agreements.
Board reconstituted; seller's continuing role papered.
Written fiduciary role map: who is a fiduciary, for what function, appointed by whom, monitored how.
Fidelity bond under 29 U.S.C. § 1112 — mandatory, protects the plan against fraud or dishonesty.
Fiduciary liability insurance — separate, protects fiduciaries against breach claims. (Companies routinely have one and believe they have both.)
Indemnification checked against 29 U.S.C. § 1110 — exculpation is void; employer indemnification generally permitted, plan indemnification is not.
Repurchase obligation study commissioned.
Annual calendar established: appraisal under 26 U.S.C. § 401(a)(28)(C), Form 5500, coverage and nondiscrimination testing, § 409(p) testing, participant statements, committee meetings with minutes.

Part 10 — Employee communication

What participants receive stated plainly: a retirement plan account, credited with shares as the internal loan amortizes, vesting on schedule, distributable on separation at the annual appraised value, with a put right under 26 U.S.C. § 409(h).
What they do not receive stated: no sellable stock, no spendable dividend, no board seat, no vote on ordinary matters. Pass-through voting only on the events in 26 U.S.C. § 409(e).
Suspense account mechanics explained — the first statements will show small balances.
Warning given that the first post-closing valuation will likely be lower, because of the debt.
Annual rhythm established: valuation meeting, plain-language plan summary, personalized statements with projections, a question channel not running through the seller.
Communication materials reviewed by counsel and retained — enthusiastic "ownership" messaging becomes an exhibit.

Part 11 — Plan document choices

Eligibility and entry — broader spreads the benefit and increases the repurchase obligation.
Vesting — faster is a better benefit and accelerates repurchase. Both effects modeled.
Allocation formula, and its interaction with § 409(p) if S status is coming.
Distribution timing and installments — the most powerful lever on the repurchase obligation. Chosen with the repurchase study in hand.
Put option mechanics within § 409(h), including installment payment with adequate security.
Recycling vs. redemption policy documented, not left to practice.
Diversification under § 401(a)(28)(B) implemented — qualified participants at 55 with 10 years.
Voting pass-through procedure, including treatment of non-directed allocated shares.
Committee authority and indemnification drafted against § 1110.
A claims procedure that works — participant disputes over account values and distributions are the ordinary litigation.

Part 12 — Ongoing fiduciary work

Appointing fiduciary monitors the trustee — the duty boards forget. Annual review of the valuation process, appraiser independence and competence, distribution administration, and trustee governance.
Continuing duty to monitor understood — Tibble v. Edison International, 575 U.S. 523 (2015) and Hughes v. Northwestern University, 595 U.S. 170 (2022).
Duties under 29 U.S.C. § 1104(a)(1) discharged: solely in participants' interest, exclusive purpose, prudence, and per plan documents.
Diversification relief under § 1104(a)(2) understood as limited to that duty — prudence still applies.
Annual valuation reviewed by the committee, with documented deliberation.
Personal liability under 29 U.S.C. § 1109 understood; enforcement under § 1132.
Committee minutes maintained.

Part 13 — The repurchase obligation

Study refreshed every two to three years.
Demographics, turnover, share appreciation, and distribution timing modeled over 20+ years.
Funding strategy chosen deliberately: operating cash, sinking fund, corporate-owned life insurance, or recycling.
Feedback loop understood: redemption reduces shares, raising per-share value, raising the next cohort's balances. Recycling avoids that but requires ongoing contributions.
Diversification right under § 401(a)(28)(B) included in the model.
Plan design levers used: distribution timing within statutory limits, installments where permitted.

Part 14 — Governance of the ESOP-owned company

Roles mapped: board (corporate duties + appointing fiduciary), trustee (shareholder; ERISA duties to participants), plan committee (administration), management (business).
Independent directors appointed — more valuable here than in most private companies, because no controlling shareholder exists.
Post-closing trustee decision made knowingly (institutional vs. internal committee), with insurance and training if internal.
Information protocol to the trustee: financial statements, board materials, notice of major developments.
Conflict and recusal protocols in writing.
Annual hat-check: role map circulated, each person confirms which capacities they hold.

Part 15 — Later transactions

Partial sale: minority discounts apply; governance protections for the trustee negotiated (board representation, information rights, protective provisions on affiliate transactions and compensation).
Second-stage sale treated as an entirely new prohibited transaction — fresh adequate consideration, trustee process, diligence, and negotiation. It inherits nothing.
Sale of the company: pass-through voting under § 409(e) operative; trustee's duty is to obtain no less than adequate consideration; real market check, independent valuation and counsel, documented deliberation.
Value diversions scrutinized on a sale: management transaction bonuses, rollover equity for executives, indemnity allocation.
Termination without a sale understood to require repurchasing every share at once.

Part 16 — Responding to an investigation

ERISA counsel engaged immediately — separately for the company, the trustee, and the seller, whose interests diverge.
Theory understood: overpayment → § 1108(e) exemption fails → prohibited transaction under § 1106 → liability under § 1109, plus excise tax under 26 U.S.C. § 4975.
Process file produced: trustee selection, appraiser selection and engagement, diligence materials, projection testing, negotiation history, deliberative minutes, fairness opinion.
Anticipated questions prepared: who selected and paid the appraiser; relationships between trustee and seller; whether projections were tested; whether anyone negotiated; how warrants were valued; whether the company could service the debt.
Understood: the substantive question is contested by experts years later; the process question is answered by contemporaneous documents or not at all.